Brain Cancer News
Cell Phone Towers and Childhood Cancer Risk (July 1, 2010)Recent findings indicate that children who are exposed to radiofrequency fields from cell phone towers before birth do not have an increased risk of early childhood cancer. This study was published in the British Medical Journal. The health effects—notably,... Continue Reading
Novel Approach Shows Promise for Glioblastoma (June 16, 2010)A new non-invasive treatment has shown promising results in patients with recurrent glioblastoma when compared with the best standard chemotherapy regimens, according to the results of a Phase III study presented at the 2010 annual meeting of the American... Continue Reading
Rindopepimut with Temodar Appears Promising in Newly Diagnosed Glioblastoma Multiforme (June 14, 2010)Maintenance therapy with rindopepimut (CDX-110) combined with Temodar® (temozolomide) resulted in a 70% progression-free rate at 5.5 months for newly diagnosed patients with glioblastoma multiforme (GBM). These findings were recently presented at the... Continue Reading
Recurrent High-grade Glioma Patients May Benefit from Hypofractionated Stereotactic Radiation Therapy (June 1, 2010)Patients with recurrent, high-grade glioma who were treated with hypofractionated stereotactic radiation therapy (H-SRT) experienced minimal side effects and a median survival of 11 months. These results were recently published in the Journal of Clinical... Continue Reading
Optimal Outcomes with Vascular Endothelial Growth Factor (VEGF) Inhibitors Require Appropriate Hypertension Assessment, Monitoring, and Management (May 28, 2010)An expert panel provided consensus recommendations for appropriate prevention, surveillance and treatment of hypertension (high blood pressure) in patients treated with vascular endothelial growth factor (VEGF) signaling pathway inhibitors. These recommendations... Continue Reading
Link Between Cell Phone Use and Brain Tumors Remains Inconclusive (May 19, 2010)A large, international study has found no conclusive evidence that cell phone use increases the risk for brain tumors, according to an early online publication in the International Journal of Epidemiology.[1] Although concerns have been raised about possible... Continue Reading
Continuous Temodar Shows Promise Against Recurrent Glioma (April 1, 2010)Among patients with recurrent malignant glioma, treatment with continuous dose-intense Temodar® (temozolomide) shows promising safety and efficacy. The results of this Phase II clinical trial were published in the Journal of Clinical Oncology. Primary... Continue Reading
Children with Ewing’s Sarcoma or Astrocytoma Most Likely to Experience Late Recurrence (February 19, 2010)Late recurrence of childhood cancers appears to occur most often in Ewing’s sarcoma and astrocytoma, according to the results of a study published in the Journal of the National Cancer Institute. As cancer treatment has improved and evolved, the number... Continue Reading
No Link Between Cell Phones and Cancer in Scandinavian Study (December 7, 2009)Brain tumor rates in four Scandinavian countries have not increased since use of cell phones became widespread in the 1990s. These results were published in the Journal of the National Cancer Institute. Although concerns have been raised about possible... Continue Reading
Oncophage ® Cancer Vaccine Shows Promise Against Glioblastoma (November 4, 2009)Among patients with recurrent or progressive, high-grade glioblastoma, treatment with the investigational Oncophage® (vitespen) cancer vaccine may improve survival. Preliminary results from a Phase II clinical trial were presented at the 2009 Joint Meeting... Continue Reading
Latest Brain Cancer News By Stage
General Brain Cancer
Cell Phone Towers and Childhood Cancer Risk (July 1, 2010)
Recent findings indicate that children who are exposed to radiofrequency fields from cell phone towers before birth do not have an increased risk of early childhood cancer. This study was published in the British Medical Journal. The health effects—notably,... Continue Reading
Novel Approach Shows Promise for Glioblastoma (June 16, 2010)A new non-invasive treatment has shown promising results in patients with recurrent glioblastoma when compared with the best standard chemotherapy regimens, according to the results of a Phase III study presented at the 2010 annual meeting of the American... Continue Reading
Rindopepimut with Temodar Appears Promising in Newly Diagnosed Glioblastoma Multiforme (June 14, 2010)Maintenance therapy with rindopepimut (CDX-110) combined with Temodar® (temozolomide) resulted in a 70% progression-free rate at 5.5 months for newly diagnosed patients with glioblastoma multiforme (GBM). These findings were recently presented at the... Continue Reading
Recurrent High-grade Glioma Patients May Benefit from Hypofractionated Stereotactic Radiation Therapy (June 1, 2010)Patients with recurrent, high-grade glioma who were treated with hypofractionated stereotactic radiation therapy (H-SRT) experienced minimal side effects and a median survival of 11 months. These results were recently published in the Journal of Clinical... Continue Reading
Optimal Outcomes with Vascular Endothelial Growth Factor (VEGF) Inhibitors Require Appropriate Hypertension Assessment, Monitoring, and Management (May 28, 2010)An expert panel provided consensus recommendations for appropriate prevention, surveillance and treatment of hypertension (high blood pressure) in patients treated with vascular endothelial growth factor (VEGF) signaling pathway inhibitors. These recommendations... Continue Reading
More General Brain Cancer